Chestnut Health Systems
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Chestnut Health Systems sits in the top decile of US sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count).
Chestnut Health Systems: 20 sponsored US clinical trials, 5 recruiting.
Chestnut Health Systems sponsors 20 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 14 completed. 3 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Substance-Related Disorders, with 3 trials.
Top-decile sponsor footprint
Chestnut Health Systems ranks in the top decile of sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
20 total, page 1 of 1
K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions
NCT06375551
Testing Implementation Strategies to Scale-up a Multicomponent Continuum of Service Intervention for Families Involved in Systems With Parental Opioid and Methamphetamine Use
NCT07365293
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
NCT06852170
Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults
NCT06414993
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
NCT06560866
Recovery Management Checkups for Opioid Use Disorder Experiment
NCT04365920
Reducing Drug Use in Justice-Involved Emerging Adults
NCT05834881
Recovery Initiation and Management After Overdose (RIMO) Experiment
NCT03895827
Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR
NCT05380440
Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) Experiment
NCT03301012
Project STAMINA (Syringe Service Telemedicine Access for Medication-assisted Intervention Through NAvigation)
NCT04575324
Teen Success Project
NCT03015805
Recovery Management Checkups for Primary Care Experiment
NCT03746756
Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse
NCT03035877
Using Smartphones to Provide Recovery Support Services
NCT02132481
Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System
NCT02672150
Reinforcing Therapist Performance
NCT01016704
Recovery Management Checkups for Women Offenders
NCT01334164
Early Re-Intervention Experiment 2
NCT01153594
Adolescent Outpatient and Continuing Care Study
NCT01381133
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 3 |
Where Chestnut Health Systems enrollment is open (later-stage tilt)
5 recruiting of 20 indexed (25% open); 14 completed (70%).
Phase mix: 3 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Substance-Related Disorders (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Chestnut Health Systems: open-pipeline peers nationwide
Peers matched on 20 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Chestnut Health Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 20 trials (± recruiting share)
- 59th Medical Wing · 20 trials · 15% recruiting
- Abiomed · 20 trials · 10% recruiting
- Agency for Healthcare Research and Quality (AHRQ) · 20 trials · 0% recruiting
- Alliance Foundation Trials · 20 trials · 15% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Abdul Latif Jameel Poverty Action Lab · 25% recruiting · 4 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
Related
What to do with this Chestnut Health Systems page
20 registered trials is a research-attention snapshot, not an endorsement of Chestnut Health Systems or any single study.
- 5 of Chestnut Health Systems's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Substance-Related Disorders is the condition Chestnut Health Systems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Substance-Related Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Chestnut Health Systems pipeline card: 20 registered trials from official public datasets.Report a data error.